Abbott grows cardiac portfolio with Amplatzer approval for valve leaks

Abbott received FDA approval for the Amplatzer device, a first-of-its-kind transcatheter device that treats paravalvular leak after valve replacement surgery, eliminating the need for additional open-heart surgery. This expands Abbott's cardiac medical device portfolio.